Category: Multiple Sclerosis

Glatiramer Overview

Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone) is an immunomodulator medication currently used to treat multiple sclerosis. Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability. While a conclusive diagnosis of multiple sclerosis requires a history of two or more episodes of ...

Read more Glatiramer Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Glatiramer Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • For Solution: 20mg/vial
  • Injection: 20mg, 20mg/ml, 40mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Glatiramer: (2 results)

Sorted by National Drug Code
  • 0378-6960 Glatiramer Acetate 20 mg/ml Subcutaneous Injection, Solution by Mylan Pharmaceuticals Inc.
  • 0378-6961 Glatiramer Acetate 40 mg/ml Subcutaneous Injection, Solution by Mylan Pharmaceuticals Inc.

Other drugs which contain Glatiramer or a similar ingredient: (2 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA